Research

First synthesis of argadin: A nanomolar inhibitor of family-18 chitinases


Reference:

Dixon, M. J., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2006. First synthesis of argadin: A nanomolar inhibitor of family-18 chitinases. European Journal of Organic Chemistry, 22, pp. 5002-5006.

Related documents:

This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below.

Official URL:

http://dx.doi.org/10.1002/ejoc.200600599

Abstract

The first synthesis of the cyclic peptide natural product, argadin is reported. Use of a solid-phase approach featuring side-chain resin attachment through histidine and a novel protecting group strategy allows rapid and efficient access to the argadin backbone, whereupon the unusual 3-amino-5-hydroxy-2-pyrrolidone moiety of the peptide is introduced by oxidative cyclisation of a homoserine residue. Argadin is shown to exist as a 5:1 mixture of diastereoisomers at the 5-hydroxy centre of the pyrrolidone ring, and inhibits a representative family-18 chitinase (ChiBl from Aspergillus fumigatus) with K-i = 33 nm. The high-resolution X-ray crystal structure of synthetic argadin in complex with the same enzyme shows the binding of a single diastereoisomer as previously observed with the authentic natural product.

Details

Item Type Articles
CreatorsDixon, M. J., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M.
DOI10.1002/ejoc.200600599
DepartmentsFaculty of Science > Pharmacy & Pharmacology
RefereedYes
StatusPublished
ID Code7778
Additional InformationID number: ISI:000242300100005

Export

Actions (login required)

View Item